# OnCo record cero-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cero-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cero-therapeutics" ;
  schema:name "CERo Therapeutics"@en ;
  schema:alternateName "CERo Therapeutics Holdings, Inc."@en ;
  schema:description "CERo Therapeutics engineers a patient's own T cells so that they can both kill cancer cells and swallow their fragments, a job normally done by other immune cells. Its first product, CER-1236, is in an early trial in acute myeloid leukaemia and related bone marrow cancers."@en ;
  schema:url <https://onco.cc/companies/cero-therapeutics/>, <https://cero.bio/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://cero.bio/>, <https://www.sec.gov/Archives/edgar/data/1870404/000121390026044040/ea0285271-10k_cero.htm>, <https://clinicaltrials.gov/study/NCT06834282> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/primary-myelofibrosis/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> .